CERN Corporation

CERN Corporation

Early Stage

Microbicidal Light Treatment for Fungal & Bacterial Vaginosis

Microbicidal Light Treatment for Fungal & Bacterial Vaginosis

Overview

Raised this Round: Raised: $442,702

Total Commitments ($USD)

Platform

StartEngine

Start Date

09/14/2022

Close Date

04/27/2023

Min. Goal
$10,000
Max. Goal
$1,070,000
Min. Investment

$500

Security Type

Equity - Common

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$0.80

Pre-Money Valuation

$12,006,620

Year Founded

2016

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2C

Margin

Low

Capital Intensity

Low

Location

Coto de Caza, California

Business Type

Growth

CERN Corporation, with a valuation of $12 million, is raising funds on StartEngine. The company is developing an effective and non-drug therapeutic treatment for fungal and bacterial vaginosis. The Cern Device uses microbicidal light to mitigate pathogens causing fungal and bacterial vaginosis to promote a healthy microbiome without using drugs. The device is the size of a tampon and can be used at home as and when needed. CERN Corporation has received utility and design patents and is in the pre-revenue and testing stages of development. Gregg A. Klang founded CERN Corporation in February 2016. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,070,000. The campaign proceeds will be used for commercial device development, clinical trials, FDA clearance, and marketing.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-43,711

$-73,704

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$8,964

$8,834

Accounts Receivable

$0

$0

Total Assets

$8,964

$8,834

Short-Term Debt

$37,208

$139,896

Long-Term Debt

$0

$0

Total Liabilities

$37,208

$139,896

Financials as of: 09/14/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
CERN Corporation on StartEngine 2022
Platform: StartEngine
Security Type: Equity - Common
Valuation: $12,006,620
Price per Share: $0.80

Follow company

Follow CERN Corporation on StartEngine 2022

Buy CERN Corporation's Deal Report

Warning: according to the close date for this deal, CERN Corporation may no longer be accepting investments.

CERN Corporation Deal Report

Get KingsCrowd’s comprehensive report on CERN Corporation including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether CERN Corporation is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the CERN Corporation deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge